Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Quest Diagnostics Incorporated (DGX) stock

Learn how to easily invest in Quest Diagnostics Incorporated stock.

Quest Diagnostics Incorporated is a diagnostics & research business based in the US. Quest Diagnostics Incorporated shares (DGX) are listed on the NYSE and all prices are listed in US Dollars. Quest Diagnostics Incorporated employs 50,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Quest Diagnostics Incorporated

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DGX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Quest Diagnostics Incorporated stock price (NYSE: DGX)

Use our graph to track the performance of DGX stocks over time.

Quest Diagnostics Incorporated shares at a glance

Information last updated 2021-07-23.
Latest market close$128.88
52-week range$104.55 - $142.14
50-day moving average $131.34
200-day moving average $127.90
Wall St. target price$145.50
PE ratio 10.4681
Dividend yield $2.3 (1.69%)
Earnings per share (TTM) $13.18

Buy Quest Diagnostics Incorporated shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Quest Diagnostics Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Quest Diagnostics Incorporated price performance over time

Historical closes compared with the close of $128.88 from 2021-06-04

1 week (2021-07-15) N/A
1 month (2021-06-25) -0.58%
3 months (2021-04-26) -2.56%
6 months (2021-01-22) N/A
1 year (2020-07-22) N/A
2 years (2019-07-22) N/A
3 years (2018-07-22) N/A
5 years (2016-07-22) N/A

Is Quest Diagnostics Incorporated under- or over-valued?

Valuing Quest Diagnostics Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quest Diagnostics Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Quest Diagnostics Incorporated's P/E ratio

Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Quest Diagnostics Incorporated shares trade at around 10x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Quest Diagnostics Incorporated's PEG ratio

Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2373. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Quest Diagnostics Incorporated's EBITDA

Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3 billion.

The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.

Quest Diagnostics Incorporated financials

Revenue TTM $10.3 billion
Operating margin TTM 25.04%
Gross profit TTM $3.7 billion
Return on assets TTM 12.45%
Return on equity TTM 29.78%
Profit margin 17.43%
Book value $51.49
Market capitalisation $16.8 billion

TTM: trailing 12 months

Shorting Quest Diagnostics Incorporated shares

There are currently 8.7 million Quest Diagnostics Incorporated shares held short by investors – that's known as Quest Diagnostics Incorporated's "short interest". This figure is 11.3% down from 9.8 million last month.

There are a few different ways that this level of interest in shorting Quest Diagnostics Incorporated shares can be evaluated.

Quest Diagnostics Incorporated's "short interest ratio" (SIR)

Quest Diagnostics Incorporated's "short interest ratio" (SIR) is the quantity of Quest Diagnostics Incorporated shares currently shorted divided by the average quantity of Quest Diagnostics Incorporated shares traded daily (recently around 1.1 million). Quest Diagnostics Incorporated's SIR currently stands at 8.18. In other words for every 100,000 Quest Diagnostics Incorporated shares traded daily on the market, roughly 8180 shares are currently held short.

However Quest Diagnostics Incorporated's short interest can also be evaluated against the total number of Quest Diagnostics Incorporated shares, or, against the total number of tradable Quest Diagnostics Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Quest Diagnostics Incorporated's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Quest Diagnostics Incorporated shares in existence, roughly 70 shares are currently held short) or 0.067% of the tradable shares (for every 100,000 tradable Quest Diagnostics Incorporated shares, roughly 67 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Quest Diagnostics Incorporated.

Find out more about how you can short Quest Diagnostics Incorporated stock.

Quest Diagnostics Incorporated's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Quest Diagnostics Incorporated.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Quest Diagnostics Incorporated's total ESG risk score

Total ESG risk: 18.33

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Quest Diagnostics Incorporated's overall score of 18.33 (as at 12/31/2018) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Quest Diagnostics Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Quest Diagnostics Incorporated's environmental score

Environmental score: 0.86/100

Quest Diagnostics Incorporated's environmental score of 0.86 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Quest Diagnostics Incorporated's social score

Social score: 10.42/100

Quest Diagnostics Incorporated's social score of 10.42 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Quest Diagnostics Incorporated's governance score

Governance score: 5.77/100

Quest Diagnostics Incorporated's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Quest Diagnostics Incorporated's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Quest Diagnostics Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Quest Diagnostics Incorporated hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Quest Diagnostics Incorporated was last rated for ESG on: 2019-01-01.

Total ESG score 18.33
Total ESG percentile 16.26
Environmental score 0.86
Environmental score percentile 1
Social score 10.42
Social score percentile 1
Governance score 5.77
Governance score percentile 1
Level of controversy 3

Quest Diagnostics Incorporated share dividends

17%

Dividend payout ratio: 16.89% of net profits

Recently Quest Diagnostics Incorporated has paid out, on average, around 16.89% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.83% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Quest Diagnostics Incorporated shareholders could enjoy a 1.83% return on their shares, in the form of dividend payments. In Quest Diagnostics Incorporated's case, that would currently equate to about $2.3 per share.

While Quest Diagnostics Incorporated's payout ratio might seem low, this can signify that Quest Diagnostics Incorporated is investing more in its future growth.

Quest Diagnostics Incorporated's most recent dividend payout was on 20 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 5 July 2021 (the "ex-dividend date").

Have Quest Diagnostics Incorporated's shares ever split?

Quest Diagnostics Incorporated's shares were split on a 2:1 basis on 20 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Quest Diagnostics Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Quest Diagnostics Incorporated shares which in turn could have impacted Quest Diagnostics Incorporated's share price.

Quest Diagnostics Incorporated share price volatility

Over the last 12 months, Quest Diagnostics Incorporated's shares have ranged in value from as little as $104.5475 up to $142.136. A popular way to gauge a stock's volatility is its "beta".

DGX.US volatility(beta: 1.03)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Quest Diagnostics Incorporated's is 1.0332. This would suggest that Quest Diagnostics Incorporated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Quest Diagnostics Incorporated overview

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. .

Quest Diagnostics Incorporated in the news

There are no recent company news

Frequently asked questions

What percentage of Quest Diagnostics Incorporated is owned by insiders or institutions?
Currently 0.504% of Quest Diagnostics Incorporated shares are held by insiders and 92.44% by institutions.
How many people work for Quest Diagnostics Incorporated?
Latest data suggests 50,000 work at Quest Diagnostics Incorporated.
When does the fiscal year end for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated's fiscal year ends in December.
Where is Quest Diagnostics Incorporated based?
Quest Diagnostics Incorporated's address is: 500 Plaza Drive, Secaucus, NJ, United States, 07094
What is Quest Diagnostics Incorporated's ISIN number?
Quest Diagnostics Incorporated's international securities identification number is: US74834L1008
What is Quest Diagnostics Incorporated's CUSIP number?
Quest Diagnostics Incorporated's Committee on Uniform Securities Identification Procedures number is: 74834L100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site